Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22220 | 332 | 38.3 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CELL PHYSIOL MOL IMAGE | Address | 19 | 76% | 4% | 13 |
2 | ANESTHET TOXICOL | Address | 6 | 50% | 2% | 8 |
3 | CELL BIOL MOL IMAGE | Address | 1 | 100% | 1% | 2 |
4 | EXCELLENCE CLIN TRIAL NEUROSCI | Address | 1 | 100% | 1% | 2 |
5 | WAN FANG MED | Address | 1 | 11% | 2% | 8 |
6 | CORE S | Address | 1 | 12% | 2% | 6 |
7 | ANIMAL EXPERIMENTAL USE | Author keyword | 1 | 50% | 0% | 1 |
8 | BIOMED SCI PROGAM | Address | 1 | 50% | 0% | 1 |
9 | BONE AND BONES METABOLISM | Author keyword | 1 | 50% | 0% | 1 |
10 | BONE GRP MRC | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CASPASE PROTEASE PATHWAY | 17 | 100% | 2% | 8 |
2 | OXIDE PROTECTS OSTEOBLASTS | 15 | 82% | 3% | 9 |
3 | INDUCED APOPTOTIC INSULTS | 8 | 75% | 2% | 6 |
4 | DONOR NITROGLYCERIN | 8 | 100% | 2% | 5 |
5 | INFLAMMATION INDUCED OSTEOPOROSIS | 5 | 47% | 2% | 8 |
6 | APOPTOTIC INSULTS | 5 | 55% | 2% | 6 |
7 | OXIDE DONOR NITROGLYCERIN | 3 | 57% | 1% | 4 |
8 | FEMORAL NECK CORTEX | 2 | 67% | 1% | 2 |
9 | L N 6 1 IMINOETHYL LYSINE | 1 | 100% | 1% | 2 |
10 | NITROGLYCERIN OINTMENT PLACEMENT | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The effects of organic nitrates on osteoporosis: a systematic review | 2013 | 8 | 44 | 50% |
Nitric oxide and bone | 2001 | 257 | 76 | 32% |
Nitric oxide: novel therapy for osteoporosis | 2008 | 18 | 91 | 41% |
Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues | 2012 | 12 | 152 | 21% |
Recent Insights into the Implication of Nitric Oxide in Osteoblast Differentiation and Proliferation during Bone Development | 2010 | 22 | 96 | 18% |
Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids | 2002 | 32 | 42 | 24% |
Nitric Oxide as a Mediator of Estrogen Effects in Osteocytes | 2014 | 0 | 70 | 37% |
Nitric oxide and bone | 1996 | 117 | 54 | 20% |
Nitric oxide and tissue destruction | 2001 | 53 | 117 | 11% |
Novel therapies in benign and malignant bone diseases | 2012 | 5 | 67 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELL PHYSIOL MOL IMAGE | 19 | 76% | 3.9% | 13 |
2 | ANESTHET TOXICOL | 6 | 50% | 2.4% | 8 |
3 | CELL BIOL MOL IMAGE | 1 | 100% | 0.6% | 2 |
4 | EXCELLENCE CLIN TRIAL NEUROSCI | 1 | 100% | 0.6% | 2 |
5 | WAN FANG MED | 1 | 11% | 2.4% | 8 |
6 | CORE S | 1 | 12% | 1.8% | 6 |
7 | BIOMED SCI PROGAM | 1 | 50% | 0.3% | 1 |
8 | BONE GRP MRC | 1 | 50% | 0.3% | 1 |
9 | CLIN LERNER MED | 1 | 50% | 0.3% | 1 |
10 | EXCELLENT CANC | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000214124 | PL BENCH CORE//ANTIDIARRHEIC//DRIED PLUM |
2 | 0.0000172365 | DRYNARIA FORTUNEI//DRYNARIAE RHIZOMA//DRYNARIA QUERCIFOLIA |
3 | 0.0000136105 | OSTEOCYTE//OSTEOCYTES//BONE FLUID FLOW |
4 | 0.0000122631 | OSTEOARTICULAR AGING//MEM 161//COMPLEXO HOSP UNIV A CORUNA CHUAC |
5 | 0.0000096164 | GRP IMMUNOBIOL//HUMAN NUTR METAB DIS LIM 25//EXPT ONCOL LIM 24 |
6 | 0.0000084741 | PERIAPICAL GRANULOMA//PERIAPICAL LESIONS//PERIAPICAL LESION |
7 | 0.0000081553 | PERIODONTAL DISEASE ETIOLOGY//FRONTIER BIOMED SCI//INFLAMMATORY PERIODONTITIS |
8 | 0.0000079141 | LIPID CHEM MOL BIOL//ENHANCING FOODS PROTECT HLTH//BONE BIOMECHANICAL STRENGTH |
9 | 0.0000077765 | NO ASPIRIN//NITROASPIRIN//NCX 4016 |
10 | 0.0000073026 | MOL INNOVAT DRUG DISCOVERY//N HYDROXYGUANIDINES//LERNER FDN |